Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Kémia discovers and develops novel small molecule therapeutics. Kémia focuses on high value disease targets that are validated, but not yet addressed by safe and effective non-injectable drugs. Kémia’s competitive advantage includes proprietary chemistries for allosteric inhibition of kinases and for modulation of GPCRs (G-protein coupled receptors), a multi-disciplinary approach to medicinal chemistry, and rigorous ADME and pharmacokinetic evaluation integrated into the lead optimization process. ( www.kemia.com )
Kemia , Inc.
5871 Oberlin Drive, Suite 100
San Diego, California 92121
USA
Tel: (858) 964-1741
Fax: (858) 964-1739